CD38 and acute myeloid leukemia: The combination of chidamide and apatinib was synergistic to reduce the cell viability and to promote apoptosis in LSC-like cell ines (including CD34+CD38− KG1α and kasumi cells) and AML progenitor cells (primary CD34+ AML cells).